المؤلفون: Scully, Marie, de la Rubia, Javier, Pavenski, Katerina, Metjian, Ara, Knöbl, Paul, Peyvandi, Flora, Cataland, Spero, Coppo, Paul, Kremer Hovinga, Johanna A, Minkue Mi Edou, Jessica, De Passos Sousa, Rui, Callewaert, Filip, Gunawardena, Sriya, Lin, Julie

المصدر: Scully, Marie; de la Rubia, Javier; Pavenski, Katerina; Metjian, Ara; Knöbl, Paul; Peyvandi, Flora; Cataland, Spero; Coppo, Paul; Kremer Hovinga, Johanna A; Minkue Mi Edou, Jessica; De Passos Sousa, Rui; Callewaert, Filip; Gunawardena, Sriya; Lin, Julie (2022). Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study. Journal of thrombosis and haemostasis, 20(12), pp. 2810-2822. Wiley-Blackwell 10.1111/jth.15892

مصطلحات موضوعية: 610 Medicine & health, 340 Law

وصف الملف: application/pdf

العلاقة: https://boris.unibe.ch/173249Test/

الإتاحة: https://doi.org/10.1111/jth.15892Test
https://boris.unibe.ch/173249/1/J_of_Thrombosis_Haemost_-_2022_-_Scully_-_Long_term_follow_up_of_patients_treated_with_caplacizumab_and_safety_and_efficacy.pdfTest
https://boris.unibe.ch/173249Test/

المؤلفون: Bergstrand, Martin, Hansson, Emma, Delaey, Bernard, Callewaert, Filip, De Passos Sousa, Rui, Sargentini‐Maier, Maria Laura

المصدر: The Journal of Clinical Pharmacology ; volume 62, issue 3, page 409-421 ; ISSN 0091-2700 1552-4604

الإتاحة: https://doi.org/10.1002/jcph.1991Test

المؤلفون: Adeyemi, Ayoade, Callewaert, Filip, Razakariasa, Francesca, Sousa, Rui de Passos

المصدر: Hematology, Transfusion and Cell Therapy ; volume 43, page S47 ; ISSN 2531-1379

مصطلحات موضوعية: Hematology, Immunology and Allergy

الإتاحة: https://doi.org/10.1016/j.htct.2021.10.1048Test
https://api.elsevier.com/content/article/PII:S2531137921011950?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2531137921011950?httpAccept=text/plainTest

المؤلفون: Peyvandi, Flora, Cataland, Spero, Scully, Marie, Coppo, Paul, Knoebl, Paul, Hovinga, Johanna A. Kremer, Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Edou, Jessica Minkue Mi, Callewaert, Filip, De Winter, Hilde

المصدر: Hematology, Transfusion and Cell Therapy ; volume 43, page S46-S47 ; ISSN 2531-1379

مصطلحات موضوعية: Hematology, Immunology and Allergy

الإتاحة: https://doi.org/10.1016/j.htct.2021.10.1047Test
https://api.elsevier.com/content/article/PII:S2531137921011949?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2531137921011949?httpAccept=text/plainTest

المؤلفون: Knoebl, Paul, Cataland, Spero, Peyvandi, Flora, Coppo, Paul, Scully, Marie, Kremer Hovinga, Johanna A., Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Minkue Mi Edou, Jessica, De Winter, Hilde, Callewaert, Filip

المصدر: Knoebl, Paul; Cataland, Spero; Peyvandi, Flora; Coppo, Paul; Scully, Marie; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2020). Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study. Journal of thrombosis and haemostasis, 18(2), pp. 479-484. Wiley-Blackwell 10.1111/jth.14679

مصطلحات موضوعية: 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://boris.unibe.ch/134991Test/

الإتاحة: https://doi.org/10.1111/jth.14679Test
https://boris.unibe.ch/134991/1/HERCULES.pdfTest
https://boris.unibe.ch/134991Test/

المؤلفون: Callewaert, Filip, Knöbl, Paul, Cataland, Spero, Peyvandi, Flora, Coppo, Paul, Scully, Marie, Kremer Hovinga, Johanna A., Metjian, Ara, De la Rubia, Javier, Pavenski, Katerina, Minkue Mi Edou, Jessica, De Winter, Hilde

مصطلحات موضوعية: ADAMTS13 protein, caplacizumab, plasma exchange, purpura, thrombotic thrombocytopenic, von Willebrand factor

جغرافية الموضوع: UMW:14557

وصف الملف: text/html

العلاقة: vignette : https://repositorium.meduniwien.ac.at/titlepage/urn/urn:nbn:at:at-ubmuw:3-59949/128Test; urn:nbn:at:at-ubmuw:3-59949; https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-59949Test; local:99146883357903331; system:AC16575811

الإتاحة: https://doi.org/10.1111/jth.14679Test
https://resolver.obvsg.at/urn:nbn:at:at-ubmuw:3-59949Test

المؤلفون: Scully, Marie, Cataland, Spero R, Peyvandi, Flora, Coppo, Paul, Knöbl, Paul, Kremer Hovinga, Johanna A, Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Callewaert, Filip, Biswas, Debjit, De Winter, Hilde, Zeldin, Robert K, HERCULES Investigators

المصدر: Scully, Marie; Cataland, Spero R; Peyvandi, Flora; Coppo, Paul; Knöbl, Paul; Kremer Hovinga, Johanna A; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Callewaert, Filip; Biswas, Debjit; De Winter, Hilde; Zeldin, Robert K; HERCULES Investigators (2019). Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine, 380(4):335-346.

مصطلحات موضوعية: Clinic for Oncology and Hematology, 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://www.zora.uzh.ch/id/eprint/175165/1/nejmoa1806311.pdfTest; info:pmid/30625070; urn:issn:0028-4793

الإتاحة: https://doi.org/10.5167/uzh-17516510.1056/NEJMoa1806311Test
https://www.zora.uzh.ch/id/eprint/175165Test/
https://www.zora.uzh.ch/id/eprint/175165/1/nejmoa1806311.pdfTest

المؤلفون: Sargentini-Maier, Maria Laura, De Decker, Philip, Tersteeg, Claudia, Canvin, Jan, Callewaert, Filip, De Winter, Hilde

المساهمون: was not funded

المصدر: Expert Review of Clinical Pharmacology ; volume 12, issue 6, page 537-545 ; ISSN 1751-2433 1751-2441

الإتاحة: https://doi.org/10.1080/17512433.2019.1607293Test

المؤلفون: Peyvandi, Flora, Scully, Marie, Kremer Hovinga, Johanna Anna, Cataland, Spero, Knöbl, Paul, Wu, Haifeng, Artoni, Andrea, Westwood, John-Paul, Mansouri Taleghani, Magnus, Jilma, Bernd, Callewaert, Filip, Ulrichts, Hans, Duby, Christian, Tersago, Dominique

المصدر: Peyvandi, Flora; Scully, Marie; Kremer Hovinga, Johanna Anna; Cataland, Spero; Knöbl, Paul; Wu, Haifeng; Artoni, Andrea; Westwood, John-Paul; Mansouri Taleghani, Magnus; Jilma, Bernd; Callewaert, Filip; Ulrichts, Hans; Duby, Christian; Tersago, Dominique (2016). Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. New England journal of medicine NEJM, 374(6), pp. 511-522. Massachusetts Medical Society MMS 10.1056/NEJMoa1505533

مصطلحات موضوعية: 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://boris.unibe.ch/79315Test/

الإتاحة: https://doi.org/10.1056/NEJMoa1505533Test
https://boris.unibe.ch/79315/1/JKH_M.Mansouri_16021105_Caplacizumab%20for%20Acquired%20Thrombotic%20Thrombocytopenic.pdfTest
https://boris.unibe.ch/79315Test/

المؤلفون: Peyvandi, Flora, Cataland, Spero, Scully, Marie, Coppo, Paul, Knoebl, Paul, Kremer Hovinga, Johanna A., Metjian, Ara, de la Rubia, Javier, Pavenski, Katerina, Minkue Mi Edou, Jessica, De Winter, Hilde, Callewaert, Filip

المصدر: Peyvandi, Flora; Cataland, Spero; Scully, Marie; Coppo, Paul; Knoebl, Paul; Kremer Hovinga, Johanna A.; Metjian, Ara; de la Rubia, Javier; Pavenski, Katerina; Minkue Mi Edou, Jessica; De Winter, Hilde; Callewaert, Filip (2021). Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis. Blood advances, 5(8), pp. 2137-2141. American Society of Hematology 10.1182/bloodadvances.2020001834

مصطلحات موضوعية: 610 Medicine & health

وصف الملف: application/pdf

العلاقة: https://boris.unibe.ch/156090Test/

الإتاحة: https://doi.org/10.1182/bloodadvances.2020001834Test
https://boris.unibe.ch/156090/1/Caplacizumab_prevents_advancesadv2020001834.pdfTest
https://boris.unibe.ch/156090Test/